Find clinical trials for Breast Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near New York, NY, USA:
study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body.The inte...
Phase 2
Stamford, Connecticut, United States and 9 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
New York, New York, United States and 19 other locations
radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...
Phase 2
New York, New York, United States and 5 other locations
Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatment naive ...
Phase 1
New York, New York, United States and 2 other locations
participants with early-stage high-risk hormone receptor positive breast cancer.The names of the study drugs involved in this study...
Phase 2
Stamford, Connecticut, United States and 11 other locations
This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...
Phase 2
Stamford, Connecticut, United States and 10 other locations
This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...
Phase 2
New York, New York, United States and 6 other locations
The goal of this protocol is to evaluate the safety and efficacy of an alternative systemic combination approach that omits or delays the use of chem...
Phase 2
New York, New York, United States and 1 other location
This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer...
New York, New York, United States and 24 other locations
This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...
Phase 2
New York, New York, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal